Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nanoform Establishes U.S. Subsidiary | Contract Pharma

What are you searching for?

Sign in
Breaking News

Nanoform Establishes U.S. Subsidiary

Sally Langa named head of U.S. sales.

By: Tiffany Coppolino

Nanoform, an innovative nanoparticle medicine enabling company, has established Nanoform USA Inc., a wholly owned subsidiary in the U.S. The company says this is a natural progression for the company as it continues to increase the impact of its award-winning nanonization technology and expand its major pharma client base in the U.S. 
 
The establishment of Nanoform USA Inc. follows the recent appointment of Sally Langa as head of U.S. dales. Ms. Langa brings 30 years of commercial experience in pharma, having held senior positions at Catalent, Patheon and Halo. The expansion also coincides with increasing interest in Nanoform’s technology within the U.S. marketplace and the company’s application for GMP status at its Finnish site, which is expected to further fuel demand for Nanoform’s proprietary CESS technology. 
 
“We are tremendously excited to have officially established our presence in the U.S. with a wholly owned subsidiary. This comes as a natural next step for our company as we continue to expand the reach of our nanonization technology,” said Prof. Edward Hæggström, chief executive officer, Nanoform.
 
Miguel Calado, vice chairman of the board, Nanoform, said, “I am thrilled we are establishing Nanoform USA Inc. With this strategic expansion, we now have a strong foundation on which to continue to grow our presence in the U.S.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters